FDA Inspection
American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc. – FDA Inspection, Jan 22, 2020
Record Details
This FDA Inspection record concerns American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc., with an inspection on January 22, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 22, 2020
- Product Type
- Biologics
View Company Profile
ID · 6caf4d60-a12d-434c-a406-deb3af2555e9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1116246
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
4- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.50(a)Determination based on screening and testing
- 21 CFR 1271.55(a)(1)Personal information included in I.D. code
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2022 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 2, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.
- FDA Inspection 1171593 - 2022-06-09
- FDA Inspection 1147861 - 2021-08-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.